黎扬斯, 岑恩妮, 王震, 涂海燕. 一例ⅢB期肺鳞癌经免疫治疗联合化疗后的策略[J]. 循证医学, 2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008
    引用本文: 黎扬斯, 岑恩妮, 王震, 涂海燕. 一例ⅢB期肺鳞癌经免疫治疗联合化疗后的策略[J]. 循证医学, 2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008
    LI Yang-si, CEN En-ni, WANG Zhen, TU Hai-yan. The Strategy for a Lung Cancer Patient in Stage Ⅲ B Undergoing Immune Checkpoint Inhibitor Plus Chemotherapy[J]. Journal of Evidence-Based Medicine, 2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008
    Citation: LI Yang-si, CEN En-ni, WANG Zhen, TU Hai-yan. The Strategy for a Lung Cancer Patient in Stage Ⅲ B Undergoing Immune Checkpoint Inhibitor Plus Chemotherapy[J]. Journal of Evidence-Based Medicine, 2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008

    一例ⅢB期肺鳞癌经免疫治疗联合化疗后的策略

    The Strategy for a Lung Cancer Patient in Stage Ⅲ B Undergoing Immune Checkpoint Inhibitor Plus Chemotherapy

    /

    返回文章
    返回